The invention provides new methods for modulating specific CMI-inducing cytokines in vivo. Such new methods result in stimulation of the cytokines IL-6, IL-12 MIP-1.beta. and MCP without substantially inducing undesired cytokines. The methods according to the invention are based upon administration of oligonucleotides containing particular structural motifs which lead to specific cytokine induction.

 
Web www.patentalert.com

< Uses of DNA-PK

< System and method for continuous data analysis of an ongoing clinical trial

> Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium

> Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors

~ 00600